PANACEA BIOTEC
|
PANACEA BIOTEC Last 5 Year Financial Ratios History
[Consolidated]
| Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | -5.43 | 176.05 | -24.11 | -31.72 | 6.16 |
| CEPS(Rs) | 0.88 | 183.20 | -16.43 | -24.57 | 15.11 |
| DPS(Rs) | - | - | - | - | - |
| Book NAV/Share(Rs) | 137.73 | 143.12 | -37.34 | 27.23 | 57.21 |
| Tax Rate(%) | 363.53 | 25.60 | -1.36 | -9.54 | 18.57 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | -20.68 | -1.90 | 11.70 | 4.68 | -29.15 |
| EBIT Margin(%) | 3.64 | 234.47 | 6.27 | -0.68 | 33.04 |
| Pre Tax Margin(%) | 2.70 | 208.46 | -22.02 | -32.66 | 10.09 |
| PAT Margin (%) | -7.12 | 155.09 | -22.32 | -35.77 | 8.22 |
| Cash Profit Margin (%) | 1.14 | 161.39 | -15.36 | -27.66 | 20.27 |
| Performance Ratios | |||||
| ROA(%) | -2.24 | 74.05 | -10.69 | -13.36 | 2.55 |
| ROE(%) | -3.92 | 332.85 | - | -75.26 | 11.39 |
| ROCE(%) | 1.94 | 217.12 | 5.36 | -0.38 | 13.44 |
| Asset Turnover(x) | 0.32 | 0.48 | 0.48 | 0.37 | 0.31 |
| Sales/Fixed Asset(x) | 0.36 | 0.54 | 0.51 | 0.41 | 0.30 |
| Working Capital/Sales(x) | 2.04 | 3.93 | 24.27 | 8.90 | -1.06 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 2.79 | 1.86 | 1.95 | 2.46 | 3.28 |
| Receivable days | 54.62 | 43.66 | 42.68 | 52.75 | 89.81 |
| Inventory Days | 159.84 | 101.55 | 89.66 | 76.86 | 166.09 |
| Payable days | 297.63 | 335.05 | 397.33 | 545.38 | 579.47 |
| Valuation Parameters | |||||
| PER(x) | - | 0.84 | - | - | 32.18 |
| PCE(x) | 123.40 | 0.81 | -10.80 | -4.46 | 13.12 |
| Price/Book(x) | 0.79 | 1.04 | -4.75 | 4.02 | 3.46 |
| Yield(%) | - | - | - | - | - |
| EV/Net Sales(x) | 1.00 | 0.54 | 2.83 | 2.43 | 4.02 |
| EV/Core EBITDA(x) | -9.89 | -160.66 | 20.44 | 23.70 | -14.34 |
| EV/EBIT(x) | 26.56 | 0.22 | 43.08 | -358.28 | 12.17 |
| EV/CE(x) | 0.36 | 0.21 | 1.50 | 0.85 | 1.35 |
| M Cap / Sales | 1.44 | 1.37 | 1.74 | 1.23 | 2.66 |
| Growth Ratio | |||||
| Net Sales Growth(%) | -30.44 | 5.83 | 14.84 | 19.13 | -22.96 |
| Core EBITDA Growth(%) | -1,972.34 | -102.58 | 55.10 | 143.60 | -238.06 |
| EBIT Growth(%) | -98.94 | 3,867.47 | 1,212.62 | -102.45 | 340.82 |
| PAT Growth(%) | -103.13 | 837.56 | 24.88 | -618.75 | 149.23 |
| EPS Growth(%) | -103.08 | 830.09 | 23.97 | -614.93 | 151.00 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.02 | 0.04 | -3.58 | 4.45 | 1.85 |
| Current Ratio(x) | 1.71 | 1.23 | 1.06 | 1.10 | 0.54 |
| Quick Ratio(x) | 1.09 | 0.95 | 0.67 | 0.86 | 0.45 |
| Interest Cover(x) | 3.89 | 9.01 | 0.22 | -0.02 | 1.44 |
| Total Debt/Mcap(x) | 0.03 | 0.04 | 0.75 | 1.11 | 0.53 |
Compare Financial Ratios of peers of PANACEA BIOTEC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PANACEA BIOTEC | ₹870.5 Cr | -6.4% | -21.9% | 18.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹356,625.0 Cr | 3% | 2.3% | 68.2% | Stock Analytics | |
| CIPLA | ₹112,938.0 Cr | 2.5% | 0.4% | 71.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹101,315.0 Cr | -1.6% | -7% | 23.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,276.9 Cr | -0.2% | -4.9% | 40.3% | Stock Analytics | |
| ZYDUS LIFESCIENCES | ₹93,921.9 Cr | 5% | 10.4% | 109.1% | Stock Analytics | |
PANACEA BIOTEC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PANACEA BIOTEC | -6.4% |
-21.9% |
18.8% |
| SENSEX | 1.3% |
2.6% |
24% |
You may also like the below Video Courses
